clinical trial · NCT06855498
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Hidradenitis Suppurativa (HS)povorcitinib
brief summary
Rollover study for participants from predetermined, Incyte-sponsored parent clinical trials of povorcitinib.
started
Feb 28, 2025
primary completion
Feb 28, 2028
completion
Feb 28, 2028
last updated
Jun 1, 2026
official title
A Phase 3b, Multicenter, Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol